UK markets closed
NIKKEI 225
38,179.46 -49.65 (-0.13%) HANG SENG
19,115.06 +151.38 (+0.80%) CRUDE OIL
79.20 +0.94 (+1.20%) GOLD FUTURES
2,343.70 -31.30 (-1.32%) DOW
39,431.64 -81.20 (-0.21%) Bitcoin GBP
50,318.72 +1,416.32 (+2.90%)
ARCT May 2024 40.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:02PM EDT. Market open.
| Previous close | 8.00 |
| Open | N/A |
| Bid | 12.00 |
| Ask | 13.70 |
| Strike | 40.00 |
| Expiry date | 2024-05-17 |
| Day's range | 8.00 - 8.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
Insider MonkeyArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2024 Earnings Call Transcript
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2024 Earnings Call Transcript May 8, 2024 Arcturus Therapeutics Holdings Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and welcome to the Arcturus Therapeutics First Quarter 2024 Earnings […]
Simply Wall St.Arcturus Therapeutics Holdings First Quarter 2024 Earnings: Beats Expectations
Arcturus Therapeutics Holdings ( NASDAQ:ARCT ) First Quarter 2024 Results Key Financial Results Revenue: US$38.0m (down...
- GuruFocus.com
Arcturus Therapeutics Holdings Inc (ARCT) (Q1 2024) Earnings Call Transcript Highlights: ...
Despite a widened net loss, Arcturus Therapeutics reports revenue growth and promising advancements in vaccine development.
© 2024 Yahoo. All rights reserved.